GUITTARD CHOCOLATE COMPANY – Trademark Portfolio
Entity Type: 03
GUITTARD CHOCOLATE COMPANY holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 27 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 1 is pending. Notable registered marks include ONYX, AMBANJA, CHUCURI, QUEVEDO, and GUITTARD. The owner is based in BURLINGAME, CA.
10 GUITTARD ROAD
BURLINGAME, CA 94010
Showing of trademarks Trademarks
Trademark Classifications
GUITTARD CHOCOLATE COMPANY's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does GUITTARD CHOCOLATE COMPANY have?
GUITTARD CHOCOLATE COMPANY has 27 U.S. trademarks filed with the USPTO. Of these, 12 registered, 1 pending, 10 abandoned, 4 cancelled.
What trademark classes does GUITTARD CHOCOLATE COMPANY file in?
GUITTARD CHOCOLATE COMPANY files trademarks across 2 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 44 (Medical Services). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are GUITTARD CHOCOLATE COMPANY's most well-known trademarks?
GUITTARD CHOCOLATE COMPANY's registered trademark portfolio includes well-known marks such as ONYX, AMBANJA, CHUCURI, QUEVEDO, and GUITTARD. These are among 12 currently registered trademarks in the portfolio.
What is GUITTARD CHOCOLATE COMPANY's trademark registration success rate?
GUITTARD CHOCOLATE COMPANY has a 46% trademark registration rate, with 12 out of 26 resolved applications resulting in successful registration. Currently, 1 application is pending review.